youtube_live
Q3 2026 earnings • in 4 days
See detailschevron_right
MPT:NYSE
Medical Properties Trust Inc
$2.70
arrow_downward
-0.37%(-0.0100) 1D
$2.71
arrow_upward
+0.37% (+0.0100)bedtimeAfter hours
Closed: Oct 23, 4:00:04 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MPT...
Open
$2.71
High
$2.72
Low
$2.64
Mkt. cap
1.61B
Avg. vol.
13.35M
Volume
8.74M
Dividend
13.33%
Quarterly dividend
$0.09
Ex-dividend date
Sep 10, 2026
52-wk high
$6.47
52-wk low
$2.61
EPS
-$0.05
Beta
1.44
Shares outstanding
597.20M
No. of employees
121
Open
$2.71
High
$2.72
Low
$2.64
Mkt. cap
1.61B
Avg. vol.
13.35M
Volume
8.74M
Dividend
13.33%
Quarterly dividend
$0.09
Ex-dividend date
Sep 10, 2026
52-wk high
$6.47
52-wk low
$2.61
EPS
-$0.05
Beta
1.44
Shares outstanding
597.20M
No. of employees
121
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
MPT Announces Third Quarter 2026 Financial Results Conference Call and Webcast
Seeking Alpha
·
3 days ago
Medical Properties Trust: The Market Is Pricing In A Disaster That Isn't There (NYSE:MPT)
Profile
Medical Properties Trust, Inc., headquartered in Birmingham, Alabama, is a real estate investment trust that invests in healthcare facilities.
As of December 31, 2025, the company owned interests in 384 facilities with a total of 39,000 beds in the United States, United Kingdom, Germany, Switzerland, Spain, Italy, Finland, Colombia, and Portugal. The facilities are leased to a total of 50 tenants: general hospitals, behavioral health facilities, urgent care facilities, and post-acute care facilities. As of December 31, 2025, its largest tenants were Circle Health Group, Priory Group, Healthcare Systems of America, Swiss Medical Network, and Lifepoint Behavioral.
The company was criticized for its former relationship with Steward Health Care, in which it purchased properties from Steward at inflated prices and negotiated leaseback transactions at inflated rents, boosting the company's earnings in the short term and enriching its executives, while misappropriating funds from hospital budgets. Steward filed bankruptcy in 2024 and MPT severed its relationship with the company. Wikipedia
About Medical Properties Trust Inc
CEOEdward K Aldag Jr
Employees121
FoundedAug 27, 2003
HeadquartersBirmingham, Alabama, United States
SectorReal estate investment trust
Websitemedicalpropertiestrust.com
Analyst ratings
Based on 6 analysts giving stock ratings to MPT in the past 3 months
Hold
Buy
2
Hold
1
Sell
3
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MPT in the last 3 months.
Highest
Current $2.70
$7.00 (+159.26%)
Average
$5.01 (+85.56%)
Lowest
$3.80 (+40.74%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Michael Mueller J.P. Morgan | Sell | Maintained | - | - | 09/18/2026 |
Austin Wurschmidt KeyBanc | Hold | Reiterated | - | - | 09/17/2026 |
John Kilichowski Wells Fargo | Sell | Reiterated | $3.80 | +40.7% | 09/01/2026 |
Unknown Analyst Bank of America Securities | Sell | Reiterated | $4.25 | +57.4% | 08/17/2026 |
Barry Oxford Colliers Securities | Buy | Maintained | $5.00 | +85.2% | 08/12/2026 |
Michael Diana Maxim Group | Buy | Reiterated | $7.00 | +159.3% | 08/11/2026 |
Michael Carroll RBC Capital | Hold | Reiterated | $4.50 | +66.7% | 06/17/2026 |
Unknown Analyst Wells Fargo | Sell | Maintained | $5.00 | +85.2% | 03/25/2026 |
Next call in 4 days
Thu, Oct 29, 11:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- /
Revenue / Est. (USD)
- / 262.54M
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 271.92M | 294.48M | 267.80M | 270.69M |
Cost of goods sold | 8.99M | 14.68M | 9.94M | 11.20M |
Cost of revenue | 8.99M | 14.68M | 9.94M | 11.20M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 37.73M | 19.43M | 32.20M | 34.77M |
Operating expense | 104.73M | 86.55M | 101.92M | 104.22M |
Total operating expenses | 113.72M | 101.23M | 111.86M | 115.43M |
Operating income | 158.20M | 193.25M | 155.94M | 155.26M |
Other non operating income | -1.50M | 12.09M | -505.00K | -1.89M |
EBT including unusual items | -66.58M | 26.10M | 285.00K | 7.79M |
EBT excluding unusual items | 24.31M | 72.88M | 22.11M | 18.11M |
Income tax expense | 10.87M | 8.51M | -32.82M | 10.08M |
Effective tax rate | -16.33% | 32.59% | -11,516.49% | 129.37% |
Other operating expenses | - | - | - | - |
Net income | -77.73M | 17.31M | 32.83M | -2.60M |
Net profit margin | -28.59% | 5.88% | 12.26% | -0.96% |
Earnings per share | - | 0.07 | 0.09 | 0.01 |
Interest and investment income | - | - | - | - |
Interest expense | -132.40M | -132.46M | -133.33M | -135.26M |
Net interest expenses | -132.40M | -132.46M | -133.33M | -135.26M |
Depreciation and amortization charges | 66.99M | 67.12M | 69.72M | 69.45M |
EBITDA | 227.68M | 262.92M | 229.29M | 228.89M |
Gain or loss from assets sale | 9.12M | -1.39M | 790.00K | -6.46M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events